Selegiline is a daily medication for treatment of Cushing's disease and for the treatment of Canine Cognitive Dysfunction Syndrome (CCDS). CCDS is an age-related neurologic syndrome characterized by various cognitive impairments such as disorientation, reduced social interaction, changes in sleep or activity patterns, and loss of housetraining.